FTCCI honoured Dr Chandrakant Agarwal for his contribution to vision 2030

Hyderabad, July 13, 2023 - The Thalassemia and Sickle Cell Society esteemed President, Dr. Chandrakant Agarwal, has been recognized for his exceptional contribution as one of the main architects behind Vision 2030. The comprehensive plan aims to revolutionize the treatment and support systems for individuals affected by thalassemia and sickle cell disorders. In light of this remarkable achievement, the Federation of Telangana Chambers of Commerce and Industry (FTCCI) has decided to present Dr. Agarwal with a Citation Certificate, acknowledging his dedicated efforts and noble cause. The Chief Advisor to the Chief Minister- Somesh Kumar Ji (IAS Retd), Padma Shri Dr GN Rao, and Anil Agarwal, President of FTCCI were present at the event.

Dr. Agarwal's pioneering work in the field of thalassemia and sickle cell disorders has significantly impacted the lives of countless individuals, fostering advancements in research, treatment, and awareness. His invaluable expertise and visionary approach have played a pivotal role in shaping Vision 2030, a comprehensive framework aimed at improving the quality of life for those affected by these conditions.

In recognition of Dr. Agarwal's tireless dedication, G N Rao, Chairman of LV Prasad Eye Hospital, along with Anil Agarwal, President of FTCCI, and several other esteemed officials, joined hands to present a memento to Dr. Chandrakant Agarwal.

On receiving the award, Dr. Chandrakant Agarwal, President TSCS said "I am deeply honoured and humbled to receive this prestigious recognition from FTCCI. This Citation Certificate serves as a testament to the collective efforts and unwavering dedication of the Thalassemia and Sickle Cell Society. It is a reaffirmation of our commitment to improving the lives of individuals affected by thalassemia and sickle cell disorders. I am grateful for the opportunity to be part of this noble cause, and I dedicate this award to all those who have supported and believed in our mission. Together, we will continue to strive for a brighter future for every individual impacted by these genetic disorders."

The Thalassemia and Sickle Cell Society, along with Dr. Agarwal, remains committed to pursuing their mission of advancing research, treatment, and support systems for thalassemia and sickle cell disorders. Their tireless efforts continue to make a lasting impact, offering hope and a better future for individuals and families facing these challenges.